Health Advocacy
NEWBarbara Loe Fisher
Interview
NVIC Conference
Style, Gonads
Brass Ovaries
By Jane Bryant NEW
New Journalism
Challenging
Status Quo
By Jane Bryant
NVIC Conference
USA NEW
How The
Judicial Review
Of The CFS/ME
NICE Guidelines
Was Lost
Jane Bryant
The One Click Group NEW
The BMJ
Vaccines Propaganda
Professor
David Salisbury
And
Trimedia
Public Relations NEW
David Southall
"A Very
Dangerous Doctor"
Panorama swims
with sharks
Lisa Blakemore Brown NEW
Dr David Salisbury
Ooops!
Never Mind Me,
I'm Basil Fawlty! NEW
ONE CLICK RESPONSE
David Salisbury
Vaccine Litigation Biomedical Test
For ME/CFS Announced
Dr Sarah Myhill
MB BS The Politics
And Commerce
Of Autism
By Lisa Blakemore Brown
Psychologist Lies Exposed
MMR Vaccine
Trial Court UK
Dr Richard Horton
Brian Deer
By Jane Bryant Poling
Vaccine/Autism Case
Mitochondrial Disfunction
ME/CFS Patients UPDATED
Feb 2008
Freedom
Of Information
Police Harassment
In The Internet Era UPDATED
Oct. 2007
One Click Response
NICE Guidelines One Click Report
Gibson Inquiry One Click Presentation
Gibson ME/CFS Inquiry How To Solve A Problem Like ME/CFS:
Why The Gibson Report Has Failed Patients Zero Risk
By Martin J. Walker Realpolitik and ME
By Martin J. Walker The Consensus Report
Family Law Reform The PACE Report The AfME Dossier Canadian Definition of ME-CFS The Weird World of Wikipedia
By Martin J. Walker Click here to email us your opinions.
| [Previous] | [Next] |
| [Previous] | [Next] |
| Baxter Files Swine Flu Vaccine Patent A Year Ahead Of Outbreak | ||
| From Lara, Health Advocate 10 July 2009 US20090060950A1 to Baxter International filed 28th August 2008 Baxter  See Baxter Vaccine Patent Application US 2009/0060950 A1 Baxter are nothing if not prepared for this 'swine flu' outbreak if the wording in this 2008 US patent application is anything to go by: "In particular preferred embodiments the composition or vaccine comprises more than one antigen.....such as influenza A and influenza B in particular selected from of one or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1, H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7, H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes." "Suitable adjuvants can be selected from mineral gels, aluminium hydroxide, surface active substances, lysolecithin, pluronic polyols, polyanions or oil emulsions such as water in oil or oil in water, or a combination thereof. Of course the selection of the adjuvant depends on the intended use. E.g. toxicity may depend on the destined subject organism and can vary from no toxicity to high toxicity." "Three different influenza strains, two A-strains Hiroshima (HR, H3N2), a New Calcdonia (NC, H1N1) and a B-strain, Malaysia (MA), were produced in Vero cell cultures. After virus propagation the infectious virus harvest is inactivated prior to purification...." I'm feeling so much better now that I know we have such competent pharmaceutical companies, well prepared for viral outbreaks at least a year ahead of time... Regards Lara ************* Related Links: * Swine Flu Vaccine Patent Application - US 2009/0060950 A1 Baxter International, Aug. 28, 2008 * Swine Flu - Lab Accident Caused 'Pandemic' Claims NEJM John Bingham, Daily Telegraph * Baxter - Live Bird Flu Virus Shipped To 18 Countries As Vaccine The Right Perspective - New York City ************* |
||
|
||
